Ophthalmology Times Europe December 2018
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Brepocitinib meets all Phase 3 end points in noninfectious uveitis
2
Duravyu misses wet AMD end point again as EyePoint pivots to DME
3
Beyond slowing atrophy: Optogenetic therapy targets vision lost to GA
4
CHMP recommends ranibizumab biosimilar Fovlussea for retinal disease
5